A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center.
Learn more about Obstetrics and Gynecology at Weill Cornell Medicine and NewYork-Presbyterian
Call today to schedule an appointment with one of our world-class doctors
View our virtual tour of Labor and Delivery at the Alexandra Cohen Hospital for Women and Newborns
Please join us for virtual learning with the Expectant Parent and Wellness Program
